Ulrike S Eggert

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School Boston, Massachusetts, USA
    PLoS Biol 2:e379. 2004
  2. ncbi Small molecule screening by imaging
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
    Curr Opin Chem Biol 10:232-7. 2006
  3. ncbi Animal cytokinesis: from parts list to mechanisms
    Ulrike S Eggert
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Biochem 75:543-66. 2006
  4. ncbi Small molecules in an RNAi world
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
    Mol Biosyst 2:93-6. 2006
  5. ncbi Actin-aggregating cucurbitacins from Physocarpus capitatus
    Katherine N Maloney
    Department of Biological Chemistry and Molecular Pharmacology, and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Nat Prod 71:1927-9. 2008
  6. ncbi Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens
    Norbert Perrimon
    Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA
    Drug Discov Today 12:28-33. 2007
  7. ncbi Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis
    Adam B Castoreno
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
    Nat Chem Biol 6:457-63. 2010
  8. ncbi Small molecule probes of cellular pathways and networks
    Adam B Castoreno
    Dana Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States
    ACS Chem Biol 6:86-94. 2011
  9. ncbi Making the cut: the chemical biology of cytokinesis
    G Ekin Atilla-Gokcumen
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA
    ACS Chem Biol 5:79-90. 2010
  10. ncbi Drugs in action
    Ulrike S Eggert
    Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Chem Biol 4:7-11. 2008

Collaborators

Detail Information

Publications10

  1. ncbi Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School Boston, Massachusetts, USA
    PLoS Biol 2:e379. 2004
    ..Our study shows that parallel RNA interference and small molecule screening is a generally useful approach to identifying active small molecules and their target pathways...
  2. ncbi Small molecule screening by imaging
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
    Curr Opin Chem Biol 10:232-7. 2006
    ..We discuss the use of model organisms such as zebrafish in screens and review different methods of target identification. The emerging field of automated image analysis is also introduced...
  3. ncbi Animal cytokinesis: from parts list to mechanisms
    Ulrike S Eggert
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA
    Annu Rev Biochem 75:543-66. 2006
    ..We also discuss the extent to which classic questions have been answered and identify major outstanding questions...
  4. ncbi Small molecules in an RNAi world
    Ulrike S Eggert
    Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA
    Mol Biosyst 2:93-6. 2006
    ..In this Opinion, we compare and contrast small molecules and RNAi. We discuss the advantages and disadvantages of both technologies focusing on timing, specificity, dose and therapeutic use...
  5. ncbi Actin-aggregating cucurbitacins from Physocarpus capitatus
    Katherine N Maloney
    Department of Biological Chemistry and Molecular Pharmacology, and Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Nat Prod 71:1927-9. 2008
    ..Preliminary mechanism of action studies indicate that the cucurbitacins cause actin aggregates and inhibit cell division...
  6. ncbi Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens
    Norbert Perrimon
    Department of Genetics, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA
    Drug Discov Today 12:28-33. 2007
    ..We then illustrate how the combination of RNAi and small-molecule HTS can lead to effective identification of targets in drug discovery...
  7. ncbi Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis
    Adam B Castoreno
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA
    Nat Chem Biol 6:457-63. 2010
    ..Rhodblocks differentially perturb Rho pathway proteins in cells and can be used to dissect the mechanism of the Rho pathway during cytokinesis...
  8. ncbi Small molecule probes of cellular pathways and networks
    Adam B Castoreno
    Dana Farber Cancer Institute, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States
    ACS Chem Biol 6:86-94. 2011
    ....
  9. ncbi Making the cut: the chemical biology of cytokinesis
    G Ekin Atilla-Gokcumen
    Dana Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA
    ACS Chem Biol 5:79-90. 2010
    ..In this review, we discuss the use of small molecule probes to perturb cytokinesis, as well as the role naturally occurring small molecule metabolites such as lipids play during cytokinesis...
  10. ncbi Drugs in action
    Ulrike S Eggert
    Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 250 Longwood Avenue, Boston, Massachusetts 02115, USA
    Nat Chem Biol 4:7-11. 2008